NEWS | March 17, 2023
St. Elizabeth Healthcare Invests $250,000 In Sense Neuro Diagnostics
CINCINNATI, OH – March 17, 2023 – Medical technology startup Sense Neuro Diagnostics has received $250,000 in funding from St. Elizabeth Healthcare in Edgewood, Kentucky. The investment will help Sense Neuro Diagnostics as the company advances clinical trials in its effort to commercialize a non-invasive technology to monitor traumatic brain injuries.
Sense Neuro Diagnostics is in the process of testing an innovative, non-invasive technology that can collect 360 data points in 2.5 seconds to detect brain hemorrhage or stroke type. This technology has the potential to help first responders, emergency department personnel, neuro ICU teams, and military field hospitals assess and monitor traumatic brain injuries and assess different stroke types.
“Innovation is one of our core values and at the root of so much that St. Elizabeth does,” says Sarah Giolando, senior vice president and chief strategy officer, St. Elizabeth Healthcare. “We are pleased to partner with Sense Neuro Diagnostics and help advance this novel technology with the goal of ultimately saving more lives in our hospitals and across Northern Kentucky and Greater Cincinnati.”
More than 20 sites across the United States, Canada, and India are currently engaged in pivotal trials to evaluate Sense Neuro Diagnostics’ in-hospital device, and five sites are evaluating its military field device.
“Our technology has the potential to be a total gamechanger for emergency rooms and hospital staff who treat people with traumatic brain injuries and stokes every day,” says Geoff Klass, CEO, Sense Neuro Diagnostics. “Sense Neuro Diagnostics is grateful for this partnership with St. Elizabeth Healthcare and we can’t wait until their talented medical professionals can apply this technology to their care first-hand.”
